Found: 66
Select item for more details and to access through your institution.
Adoptive immunotherapy for Hodgkin's lymphoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Administration of Latent Membrane Protein 2–Specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus–Positive Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 4, p. 342
- By:
- Publication type:
- Article
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells.
- Published in:
- Nucleic Acids Research, 2015, v. 43, n. 3, p. 1770, doi. 10.1093/nar/gkv017
- By:
- Publication type:
- Article
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
- Published in:
- Nature Medicine, 2008, v. 14, n. 11, p. 1264, doi. 10.1038/nm.1882
- By:
- Publication type:
- Article
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
- Published in:
- Nature Medicine, 2006, v. 12, n. 10, p. 1160, doi. 10.1038/nm1475
- By:
- Publication type:
- Article
Hitchhiker's guide to the T cell.
- Published in:
- Nature Medicine, 2005, v. 11, n. 10, p. 1051, doi. 10.1038/nm1005-1051
- By:
- Publication type:
- Article
Anti-Interleukin-10 Antibodies in Patients with Chronic Active Epstein-Barr Virus Infection.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 6, p. 1454
- By:
- Publication type:
- Article
T‐cell receptor sequencing demonstrates persistence of virus‐specific T cells after antiviral immunotherapy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. 206, doi. 10.1111/bjh.16053
- By:
- Publication type:
- Article
Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.
- Published in:
- Journal of Clinical Apheresis, 1999, v. 14, n. 3, p. 154, doi. 10.1002/(SICI)1098-1101(1999)14:3<154::AID-JCA9>3.0.CO;2-K
- By:
- Publication type:
- Article
Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140744
- By:
- Publication type:
- Article
Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 2, p. 258, doi. 10.1093/infdis/jiv022
- By:
- Publication type:
- Article
Immunotherapy for Epstein-Barr virus-associated cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1998, v. 90, n. 9, p. 89
- By:
- Publication type:
- Article
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 3, p. 602, doi. 10.1038/mt.2014.243
- By:
- Publication type:
- Article
Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 1, p. 179, doi. 10.1038/mt.2014.192
- By:
- Publication type:
- Article
Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 6, p. 1211, doi. 10.1038/mt.2014.47
- By:
- Publication type:
- Article
Systemic Inflammatory Response Syndrome After Administration of Unmodified T Lymphocytes.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 6, p. 1134, doi. 10.1038/mt.2014.48
- By:
- Publication type:
- Article
Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 3, p. 623, doi. 10.1038/mt.2013.262
- By:
- Publication type:
- Article
Harnessing the Immune System to Potentiate Oncolytics.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 239, doi. 10.1038/mt.2013.295
- By:
- Publication type:
- Article
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2113, doi. 10.1038/mt.2013.151
- By:
- Publication type:
- Article
Adenovirus Immunity: X Marks the Spot.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 12, p. 2197, doi. 10.1038/mt.2012.240
- By:
- Publication type:
- Article
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 8, p. 1622, doi. 10.1038/mt.2012.130
- By:
- Publication type:
- Article
T lymphocytes targeting native receptors.
- Published in:
- Immunological Reviews, 2014, v. 257, n. 1, p. 39, doi. 10.1111/imr.12133
- By:
- Publication type:
- Article
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 2, p. 81, doi. 10.1038/sj.cgt.7700664
- By:
- Publication type:
- Article
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma.
- Published in:
- International Journal of Cancer, 2001, v. 93, n. 5, p. 706, doi. 10.1002/ijc.1396
- By:
- Publication type:
- Article
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 285, p. 1, doi. 10.1126/scitranslmed.aaa2546
- By:
- Publication type:
- Article
Antigen-specific T cell therapies for cancer.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 20, p. R67, doi. 10.1093/hmg/ddv270
- By:
- Publication type:
- Article
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 242, p. 1, doi. 10.1126/scitranslmed.3008825
- By:
- Publication type:
- Article
Current challenges for CAR T-cell therapy of acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies ( PACT) program.
- Published in:
- Transfusion, 2015, v. 55, n. 3, p. 674, doi. 10.1111/trf.12881
- By:
- Publication type:
- Article
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.
- Published in:
- Transfusion, 2009, v. 49, n. 4, p. 786, doi. 10.1111/j.1537-2995.2008.02027.x
- By:
- Publication type:
- Article
Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2258, doi. 10.1038/mt.2011.167
- By:
- Publication type:
- Article
Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2239, doi. 10.1038/mt.2011.179
- By:
- Publication type:
- Article
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2133, doi. 10.1038/mt.2011.131
- By:
- Publication type:
- Article
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 6, p. 1008, doi. 10.1038/mt.2011.65
- By:
- Publication type:
- Article
A Th1-inducing Adenoviral Vaccine for Boosting Adoptively Transferred T Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 211, doi. 10.1038/mt.2010.223
- By:
- Publication type:
- Article
T Cells Expressing Constitutively Active Akt Resist Multiple Tumor-associated Inhibitory Mechanisms.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 11, p. 2006, doi. 10.1038/mt.2010.185
- By:
- Publication type:
- Article
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133
- By:
- Publication type:
- Article
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 9, p. 1616, doi. 10.1038/mt.2009.140
- By:
- Publication type:
- Article
Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 5, p. 880, doi. 10.1038/mt.2009.34
- By:
- Publication type:
- Article
Dendritic Cell Function After Gene Transfer with Adenovirus-calcium Phosphate Co-precipitates.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 2, p. 386, doi. 10.1038/sj.mt.6300029
- By:
- Publication type:
- Article
266. Gene Modification of T Antigen Presenting Cells for the Induction of Antitumor Immunity.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S101, doi. 10.1016/j.ymthe.2006.08.320
- By:
- Publication type:
- Article
627. Calcium Phopspate Precipitation of Adenovirus Enhances Gene Delivery into Human Dendritic Cells.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S242, doi. 10.1016/j.ymthe.2006.08.702
- By:
- Publication type:
- Article
766. Immunotherapy for Her2-Positive Medulloblastoma: Regression of Experimental Tumors by Transfer of Her2-Redirected T Cells In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S296, doi. 10.1016/j.ymthe.2006.08.851
- By:
- Publication type:
- Article
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
- Published in:
- Molecular Therapy, 2005, v. 12, n. 5, p. 933, doi. 10.1016/j.ymthe.2005.04.016
- By:
- Publication type:
- Article
1074. The Use of Genetically Modified Antigen Presenting Cells to Generate Donor-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against CMV and Adenoviral Antigens for Clinical Use
- Published in:
- 2005
- By:
- Publication type:
- Abstract